Cargando…
A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo
BACKGROUND: In search of a suitable GSH-depleting agent, a novel copper complex viz., copper N-(2-hydroxyacetophenone) glycinate (CuNG) has been synthesized, which was initially found to be a potential resistance modifying agent and later found to be an immunomodulator in mice model in different dos...
Autores principales: | Mookerjee, Ananda, Basu, Jayati Mookerjee, Majumder, Surajit, Chatterjee, Shilpak, Panda, Gouri S, Dutta, Pranabananda, Pal, Smarajit, Mukherjee, Pratima, Efferth, Thomas, Roy, Syamal, Choudhuri, Soumitra K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1660546/ https://www.ncbi.nlm.nih.gov/pubmed/17107616 http://dx.doi.org/10.1186/1471-2407-6-267 |
Ejemplares similares
-
A Novel Copper Chelate Modulates Tumor Associated Macrophages to Promote Anti-Tumor Response of T Cells
por: Chatterjee, Shilpak, et al.
Publicado: (2009) -
Bilateral chylothorax, chylopericardium and chylous ascitis
por: Kashyap, Anil, et al.
Publicado: (2011) -
Ehrlich tumor inhibition using doxorubicin containing liposomes
por: Elbialy, Nihal Saad, et al.
Publicado: (2015) -
Targeting Mitochondrial Cell Death Pathway to Overcome Drug Resistance with a Newly Developed Iron Chelate
por: Ganguly, Avishek, et al.
Publicado: (2010) -
A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
por: Mookerjee, Ananda, et al.
Publicado: (2018)